Middle Mist Pharmaceuticals Private Limited
About Middle Mist Pharmaceuticals Private Limited
Data last updated:
Middle Mist Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33100TN2015PTC101687. Its GSTIN is 33AAJCM8577C1ZA (Tamil Nadu).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.71 Cr. It is led by directors Kuppusamy Ramadas (Whole-Time Director) and Rakesh Sharma Devarajan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No.1/230 Leelavathi Nagar Kundrathur Main Road Chikarayapuram, Chennai, Tamil Nadu, India – 600069.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.96 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹57.23 Lakh (net margin 4.4%) and EBITDA of ₹1.21 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 15% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.25 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Middle Mist Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDoor No.1/230 Leelavathi Nagar Kundrathur Main Road Chikarayapuram, Chennai, Tamil Nadu, India – 600069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Middle Mist Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Middle Mist Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Financials of Middle Mist Pharmaceuticals Private Limited
FY 2025 filings availableMiddle Mist Pharmaceuticals Private Limited reported revenue of ₹12.96 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Board of directors of Middle Mist Pharmaceuticals Private Limited
Middle Mist Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuppusamy Ramadas | Whole-Time Director | 05 Aug 2015 | 11 Years 2 Months | Current |
| Rakesh Sharma Devarajan | Whole-Time Director | 05 Aug 2015 | 11 Years 2 Months | Current |
Peer comparison
Middle Mist Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meddoxx Pharmaceuticals Private Limited | ₹13.03 Cr (FY 2025) | 14.0% | Kozhikode, Kerala, India | |||
| Aster Medicines Private Limited | ₹13 Cr (FY 2025) | 20.0% | Patna, Bihar, India | |||
| Middle Mist Pharmaceuticals Private Limitedthis company | ₹12.96 Cr (FY 2025) | ₹57.23 Lakh | 4.4% | -6.0% | Chennai, Tamil Nadu, India | |
| Galen Pharmaceuticals Limited | ₹12.87 Cr (FY 2025) | -15.0% | Vadodara, Gujarat, India | |||
| C and C Organics Private Limited | ₹12.84 Cr (FY 2025) | 31.0% | Delhi, India |
To see the full peer comparison of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Auditor
Middle Mist Pharmaceuticals Private Limited is audited by SUBRAMANIAN & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBRAMANIAN & ASSOCIATES | FY 2024 | 012360S |
Shareholding
The shareholding of Middle Mist Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2024 | 100882587 | Others | ₹2 Cr | Open | |
| 02 May 2022 | 100572081 | Axis Bank Limited | ₹25 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Middle Mist Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Tirunelveli, Tamil Nadu | Criminal case | Filed against the company by an individual | Disposed |
| District court, Tirunelveli, Tamil Nadu | Criminal case | Filed against the company by an individual | Disposed |
| District court, Tirunelveli, Tamil Nadu | Criminal miscellaneous application | Filed against the company | Disposed |
To see the full case history of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Middle Mist Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Middle Mist Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAJCM8577C1ZA | Tamil Nadu | Active | 03 Nov 2017 |
To see the full GST registrations and return filing status of Middle Mist Pharmaceuticals Private Limited, buy the company report.
Recent activity
Middle Mist Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Kuppusamy Ramadas was appointed as Whole-Time Director on 05 Aug 2015.
Frequently asked questions
Middle Mist Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 2015 (11+ years old) and is registered under CIN U33100TN2015PTC101687.
Middle Mist Pharmaceuticals has 2 current directors:
- Kuppusamy Ramadas - Whole-Time Director
- Rakesh Sharma Devarajan - Whole-Time Director
The latest financial statements of Middle Mist Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Middle Mist Pharmaceuticals is 33AAJCM8577C1ZA, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Middle Mist Pharmaceuticals is U33100TN2015PTC101687. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Middle Mist Pharmaceuticals has 3 court cases on record: 3 filed against it.
Middle Mist Pharmaceuticals was incorporated on 05 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Middle Mist Pharmaceuticals by revenue are Meddoxx Pharmaceuticals Private Limited, Aster Medicines Private Limited, Galen Pharmaceuticals Limited, C and C Organics Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kuppusamy Ramadas was appointed as Whole-Time Director on 05 Aug 2015. Rakesh Sharma Devarajan was appointed as Whole-Time Director on 05 Aug 2015.
The registered office of Middle Mist Pharmaceuticals is at Door No.1230 Leelavathi Nagar Kundrathur Main Road Chikarayapuram, Chennai, Tamil Nadu, India – 600069.
Middle Mist Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.